
About Corvid Pharmaceuticals Private Limited
Data last updated:
Corvid Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 28 August 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33100MH2012PTC235053. Its GSTIN is 27AAECC9961B1ZM (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajesh Chandrakumar Hedaoo and Swati Rajesh Hedaoo.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Plot No. 51 Road No.3 Sector 1/S New Panvel (E), Navi Mumbai, Maharashtra, India – 410206.
As per the financials filed for FY 2022, the company reported a revenue of ₹32.72 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹1.41 Lakh (net margin 4.3%) and EBITDA of ₹2.11 Lakh (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 15% over five years.
The company is associated with 1 brand: Corvid pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website corvidpharma.in.
Company details
Contact details
Corvid Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is corvidpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 51 Road No.3 Sector 1/S New Panvel (E), Navi Mumbai, Maharashtra, India – 410206
- IndustryPharma, API Manufacturers
To see the full contact details of Corvid Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Corvid Pharmaceuticals operates one associated brand: Corvid pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures finished formulations, APIs, and intermediates for the pharmaceutical industry. | corvidpharma.in |
Business activity
The main business activity of Corvid Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Corvid Pharmaceuticals Private Limited, buy the company report.
Financials of Corvid Pharmaceuticals Private Limited
FY 2022 filings availableCorvid Pharmaceuticals Private Limited reported revenue of ₹32.72 Lakh (down 22% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 22% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Corvid Pharmaceuticals Private Limited, buy the company report.
Board of directors of Corvid Pharmaceuticals Private Limited
Corvid Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Chandrakumar Hedaoo Also directs: Gusto Life Sciences Private Limited, Apicem Technobuild Private Limited, Ascent Total Solution Private Limited and 1 more | Director | 26 May 2016 | 10 Years 5 Months | Current |
| Swati Rajesh Hedaoo Also directs: Gusto Life Sciences Private Limited | Director | 28 Aug 2012 | 14 Years 2 Months | Current |
| Vijay Ramchandra Kolhekar | Director | 28 Aug 2012 | 14 Years 2 Months | Current |
| Harendra Singh Also directs: Onus Equipments Private Limited, Hapec Services Private Limited | Director | 28 Aug 2012 | 14 Years 2 Months | Current |
Auditor
Corvid Pharmaceuticals Private Limited is audited by A T UPADHYE & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A T UPADHYE & CO | FY 2019 | 111175W |
Shareholding
The shareholding of Corvid Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Corvid Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Corvid Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Corvid Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Corvid Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECC9961B1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Corvid Pharmaceuticals Private Limited, buy the company report.
Recent activity
Corvid Pharmaceuticals Private Limited has 7 board changes on record since 2012: 4 appointments and 3 cessations. The latest: Supriya Sanjay Aher ceased to be Director on 17 Mar 2017.
Frequently asked questions
Corvid Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 28 August 2012 (14+ years old) and is registered under CIN U33100MH2012PTC235053.
Corvid Pharmaceuticals has 4 current directors:
- Rajesh Chandrakumar Hedaoo - Director
- Swati Rajesh Hedaoo - Director
- Vijay Ramchandra Kolhekar - Director
- Harendra Singh - Director
The latest financial statements of Corvid Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Corvid Pharmaceuticals is 27AAECC9961B1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Corvid Pharmaceuticals is U33100MH2012PTC235053. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Corvid Pharmaceuticals was incorporated on 28 August 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Supriya Sanjay Aher ceased to be Director on 17 Mar 2017. Rajesh Chandrakumar Hedaoo was appointed as Director on 26 May 2016. Sarika Ganesh Vyavahare ceased to be Director on 26 May 2016. Corvid Pharmaceuticals has 7 board changes on record in total.
Corvid Pharmaceuticals can be reached through the website corvidpharma.in. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Corvid Pharmaceuticals is at Plot No. 51 Road No.3 Sector 1S New Panvel E, Navi Mumbai, Maharashtra, India – 410206.
Corvid Pharmaceuticals operates in the pharma industry, in the api manufacturers segment.

